Evidence map›Paper›PMID 33553012›Full record

ArticleJournal of diabetes and metabolic disorders2020

Association of microbiota-derived propionic acid and Alzheimer's disease; bioinformatics analysis.

Morteza Aliashrafi, Mohammad Nasehi, Mohammad-Reza Zarrindast, Mohammad Taghi Joghataei, Hakimeh Zali, Seyed Davar Siadat

Open access · greenAbstract read
In one paragraph

Article in Journal of diabetes and metabolic disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Morteza AliashrafiDepartment of Cognitive Neuroscience, Institute for Cognitive Science Studies, Tehran, Iran.
Mohammad NasehiDepartment of Cognitive Neuroscience, Institute for Cognitive Science Studies, Tehran, Iran.
Mohammad-Reza ZarrindastDepartment of Cognitive Neuroscience, Institute for Cognitive Science Studies, Tehran, Iran.
Mohammad Taghi JoghataeiMolecular and Cellular Research Center, Iran University of Medical Sciences, Tehran, Iran.
Hakimeh ZaliProteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Seyed Davar SiadatMicrobiology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Institute for Cognitive Science Studies · IRIran University of Medical Sciences · IRShahid Beheshti University · IRShahid Beheshti University of Medical Sciences · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMicrobiota-derived metabolites could alter the brain tissue toward the neurodegeneration disease. This study aims to select the genes associated with Propionic acid (PPA) and compromise Alzheimer's disease (AD) to find the possible roles of PPA in AD pathogenesis.

methodsMicrobiota-derived metabolites could alter the brain tissue toward the neurodegeneration disease. This study aims to select the genes associated with Propionic acid (PPA) and compromise Alzheimer's disease (AD) to find the possible roles of PPA in AD pathogenesis.

resultsAmongst all genes associated with PPA and AD, 284 genes to be shared by searching databases and were subjected to further analysis. AD-PPA genes mainly involved in cancer, bacterial and virus infection, and neurological and non-neurological diseases. Gene Ontology and pathway analysis covered the most AD hallmark, such as amyloid formation, apoptosis, proliferation, inflammation, and immune system. Network analysis revealed hub and bottleneck genes. MCODE analysis also indicated the seed genes represented in the significant subnetworks.

conclusionsPPA interacted genes implicated in AD act through pathways initiate neuronal cell death. In sum up, AD-PPA shared genes exhibited evidence that supports the idea PPA secreted from bacteria could alter brain physiology toward the emerging AD signs. This idea needs to confirm by more future investigation in animal models.

Indexed as

Alzheimer’s diseaseBioinformaticsMicrobiotaPropionic acidSystem biology

Identifiers

PMID33553012
PMCPMC7843825
OpenAlexW3037390806

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.